Lilly Clashes With Valeant Over Permax Liability Costs
As Eli Lilly and Co. faces product liability claims over its discontinued drug Permax, the drugmaker has sued Valeant Pharmaceuticals International to force the bridling licensee to shoulder its share of...To view the full article, register now.
Already a subscriber? Click here to view full article